hotspot -WSS

hotspot

author：hotspot 2025-10-02 17:21:57 - browse：28272

LONDON — In a bid to expand its pipeline of inflammation-targeting drugs, Sanofi said Tuesday it was acquiring California-based Inhibrx in a deal worth up to $2.2 billion.

The core of the deal is Inhibrx’s experimental therapy for AATD, a disease that progressively damages the lungs and liver. The medicine, INBRX-101, is designed to reduce inflammation and stave off further damage to the tissue. Inhibrx has completed Phase 1 testing of the drug and is enrolling patients in a Phase 2 trial.

Inhibrx’s other drug candidates, including its line of cancer-targeting immunotherapies, will be portioned out into a new company that will continue to be called Inhibrx. Mark Lappe, the founder and CEO of Inhibrx, will lead the spun-out company.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： House panel takes first step toward fixing drug shortages

focus

WSS

Accuser who called Kevin Spacey 'vile sexual predator' admits he joked about incident

Free Covid tests will again be offered to all U.S. households

Medicare wants to send $9 billion to 340B hospitals

Senate bill would ban some hospital facility fees

DeSantis defends odds vs. Trump, despite early poll gap: 'We've worked really hard'

Eisai exec who led development of Alzheimer’s drug to retire

hotspot

hotspot

Wikipedia

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

See Ryan Reynolds, Hugh Jackman suited up in 1st look at 'Deadpool 3': Photo

Novavax promises a turnaround & Lilly roils the obesity market

House panel takes first step toward fixing drug shortages

Trump demands the U.S. pay no more for drugs than other countries … again

FDA weighs limits of animal data in assessing artificial wombs

Cancer drug shortages should be causing more outrage

Eisai exec who led development of Alzheimer’s drug to retire

Hollywood unions extend contract negotiations for actors

US sending controversial cluster munitions to Ukraine until other ammo is ready: Kirby

focus

Free Covid tests will again be offered to all U.S. households

Medicare wants to send $9 billion to 340B hospitals

David Liu startup to focus on CRISPR delivery

Judge agrees to delay next hearing in Trump classified documents case

Home health providers sue Medicare over payment cuts

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

entertainment

hotspot

focus

knowledge